| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/30/2000 | EP1030924A1 Polypeptides having uroporphyrinogen decarboxylase activity and nucleic acids encoding same |
| 08/30/2000 | EP1030923A2 Method for producing virus-like particles on the basis of polyoma viruses |
| 08/30/2000 | EP1030922A1 $i(dull1) CODING FOR A STARCH SYNTHASE AND USES THEREOF |
| 08/30/2000 | EP1030921A2 SOYBEAN HOMOLOG OF SEED-SPECIFIC TRANSCRIPTION ACTIVATOR FROM $i(PHASEOLUS VULGARIS) |
| 08/30/2000 | EP1030920A1 Methods for modulating nerve cell function |
| 08/30/2000 | EP1030919A2 Cdk2 protein and cdk2 protein complexes |
| 08/30/2000 | EP1030918A2 Slit polypeptide and method of modulation of robo with ligands |
| 08/30/2000 | EP1030917A1 Transcriptionally regulated g protein-coupled receptor |
| 08/30/2000 | EP1030916A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
| 08/30/2000 | EP1030915A1 A novel gene and uses therefor |
| 08/30/2000 | EP1030914A2 Antisense oligonucleotides against tenascin for treating vitiligo |
| 08/30/2000 | EP1030913A2 Nucleic acid catalysts with endonuclease activity |
| 08/30/2000 | EP1030911A1 Human aspartic proteases |
| 08/30/2000 | EP1030910A1 Anti-cocaine catalytic antibody |
| 08/30/2000 | EP1030908A1 Genetically-modified myogenic progenitors and their use in cell and gene therapy |
| 08/30/2000 | EP1030867A1 Mammalian milk growth factor |
| 08/30/2000 | EP1030866A2 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids |
| 08/30/2000 | EP1030865A2 Th2 CELL DEPLETION; COMPOSITIONS; METHODS |
| 08/30/2000 | EP1030861A1 Modification of virus tropism and host range by viral genome shuffling |
| 08/30/2000 | EP1030860A1 Dna regulatory element for the expression of transgenes in neurons of the mouse forebrain |
| 08/30/2000 | EP1030859A1 Ras-binding protein (pre1) |
| 08/30/2000 | EP1030858A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport |
| 08/30/2000 | EP1030690A1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype |
| 08/30/2000 | EP1030685A2 Essential bacterial genes and their use |
| 08/30/2000 | EP1030684A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response |
| 08/30/2000 | EP1030683A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 08/30/2000 | EP1030678A1 High throughput method for functionally classifying proteins identified using a genomics approach |
| 08/30/2000 | EP1030658A1 Method of building and maintaining bone |
| 08/30/2000 | EP1030656A1 Administering active substances by using the capsid produced out of the polyoma virus vp1 protein |
| 08/30/2000 | EP1030557A1 Protein delivery by secretory gland expression |
| 08/30/2000 | EP1006783A4 Shoot meristem specific promoter sequences |
| 08/30/2000 | EP0918845A4 Cleavable signal element device and method |
| 08/30/2000 | EP0883693B1 Method for quantitative determination of a nucleic acid in solution by measurement of the electrical conductivity and apparatus therefor |
| 08/30/2000 | EP0833942B1 Process for the transcriptionless amplification of nucleic acids |
| 08/30/2000 | EP0744888B1 Corn grains and products with improved oil composition |
| 08/30/2000 | EP0671946B1 Immunoreactive peptides from epstein-barr virus |
| 08/30/2000 | EP0636187B1 Nucleotidic sequences hybridizing specifically with a campylobacter jejuni genomic nucleic sequence |
| 08/30/2000 | EP0536270B1 Enzymatic hydrolysis of starch to glucose, using a genetically engineered enzyme |
| 08/30/2000 | EP0248819B2 Recombinant fibroblast growth factors |
| 08/30/2000 | CN1265159A Detection of wheat fungal pathogens using polymerase chain reaction |
| 08/30/2000 | CN1265158A Nucleic acid sequence analysis |
| 08/30/2000 | CN1265157A Computer method and system for correlating sequencing data by MS |
| 08/30/2000 | CN1265156A Amplification and other enzymatic reactions preformed on nucleic acid arrays |
| 08/30/2000 | CN1265155A Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
| 08/30/2000 | CN1265152A Prodn. of human mutant, proteins in human cells by homologous recombination |
| 08/30/2000 | CN1265151A Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male fertility and uses thereof in hybrid crop prodn. |
| 08/30/2000 | CN1265150A Genetic method for controlling sprouting |
| 08/30/2000 | CN1265149A Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 08/30/2000 | CN1265148A Anticoagulant fusion protein anchored to cell membrane |
| 08/30/2000 | CN1265147A Method for producing biotin |
| 08/30/2000 | CN1265146A 细胞分裂素氧化酶 Cytokinin oxidase |
| 08/30/2000 | CN1265145A Hypersensitive response elicitor fragments and uses thereof |
| 08/30/2000 | CN1265144A Identification of human cell lines for prodn. of human proteins by endogenous gene activation |
| 08/30/2000 | CN1265143A Prodn. of erythropoietin by endogenous gene activation |
| 08/30/2000 | CN1265049A Polyethylenimine-based biomolecule arrays |
| 08/30/2000 | CN1264744A Method for large-scale cDNA clone and sequencing by cyclic difference subtraction |
| 08/30/2000 | CN1264742A Integrative recombination of genetic substance in host cells |
| 08/30/2000 | CN1264741A Human adenosine-diphosphate ribosyglucose hydrolase protein and its coding sequence |
| 08/30/2000 | CN1264740A Human UMP-CMP kinase and its coding sequence, preparing process and application |
| 08/30/2000 | CN1264739A Human protein and its coding sequence, preparing process and application |
| 08/30/2000 | CN1264738A Homogeneous and repetitive genetic manipulation technique of lathal gene for obtaining and keeping real hybridized seed |
| 08/30/2000 | CN1264737A Efficient receptor technique for introducing exogenous genetic material |
| 08/30/2000 | CN1264736A Recombination gluconokinase and its preparing process |
| 08/30/2000 | CN1264710A Modification and preparation of human interleukin 11 |
| 08/30/2000 | CN1055970C Plasmid derived from lactobacillus delbrueckii SP. |
| 08/30/2000 | CN1055969C Synthetic gene of rice rilulose-1,5-diphosphocarboxylase/oxygenase majar subunit |
| 08/30/2000 | CN1055968C Colon bacillus cytosine ammonialyse gene and new substance containing same |
| 08/29/2000 | US6111258 Method for working in a specimen and a stage for the method |
| 08/29/2000 | US6111255 Methods of screening for a tumor or tumor progression to the metastatic state |
| 08/29/2000 | US6111167 Nucleotide and amino acid sequences of polypeptide involved in cell development and apoptosis; for transgenic plants |
| 08/29/2000 | US6111166 Transgenic mice expressing human Fcα and β receptors |
| 08/29/2000 | US6111165 Production of human recombinant collagen in the milk of transgenic animals |
| 08/29/2000 | US6111116 Dibenzorhodamine dyes |
| 08/29/2000 | US6111096 Device for insertion into pressure-modulation apparatus; includes electrode array system, tubes interconnecting the electrodes, and electrical terminals; for highly selective, efficient, low salt process |
| 08/29/2000 | US6111095 Capped synthetic RNA, analogs, and aptamers |
| 08/29/2000 | US6111094 Enhanced antisense modulation of ICAM-1 |
| 08/29/2000 | US6111093 Nucleotide sequence of cd antigen; for diagnosis and immunotherapy of related immune disorders |
| 08/29/2000 | US6111091 Nucleotide sequence of ionotropic glutamate receptor; probes to identify and isolate related human receptor subunits; drug screening assays to identify agonists, antagonists, and modulators |
| 08/29/2000 | US6111090 Isolated or recombinant polynucleotide encodes a polypeptide expressed on activated t cells; treatment and diagnosis of abnormal immune responses such as t cell immune deficiency; antiinflammatory agents; immunosuppressants |
| 08/29/2000 | US6111089 Nucleic acid encoding a defined mouse amino acid sequence of a protein involved in embryo implantation; vaccine can be used as antifertility agent |
| 08/29/2000 | US6111087 Expression of a foamy virus envelope protein |
| 08/29/2000 | US6111081 Lactoferrin variants and uses thereof |
| 08/29/2000 | US6111078 Staphylococcus aureus rsbU-1 |
| 08/29/2000 | US6111076 Human G-protein coupled receptor (HIBCD07) |
| 08/29/2000 | US6111075 Protese-activated receptor PAR4 (ZCHEMR2) |
| 08/29/2000 | US6111074 Amino acid sequence of polypeptide from the uridine monophosphate kinase family; for screening bactericides and bacteriostats; for diagnosis and prophylaxis of infections |
| 08/29/2000 | US6111070 Polypeptides encoded by octopine T-DNA open reading frames |
| 08/29/2000 | US6110916 For transfection/drug delivery of macromolecules and other compounds into cells |
| 08/29/2000 | US6110902 Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine |
| 08/29/2000 | US6110900 Nucleic acid ligands |
| 08/29/2000 | US6110899 LICC of Streptococcus pneumoniae |
| 08/29/2000 | US6110898 By administration of an antigen-encoding polynucleotide preparation to a mucosal inductor site in the mucosal tissue of the host; target protein antigen is administered through its expression by a recombinant gene expression vector |
| 08/29/2000 | US6110745 Contacting nucleic acid with solution of non-cationic and cationic lipids, removing aqueous portion, removing organic solvent portion to form complex in the form of a film, and hydrating complex to form particle |
| 08/29/2000 | US6110744 Diminishing viral gene expression by promoter replacement |
| 08/29/2000 | US6110743 Vector having at least two oncogenes, a pair of genetic elements which are recombination sites flanking the oncogenes, and another gene; for transformed cells which produce insulin and can be transplanted into human diabetic patients |
| 08/29/2000 | US6110742 Nucleotide sequences of nuclease resistant antisense agent which modulates acetylcholinesterase production in the central nervous system; treatment of alzheimer's disease with reduced side effects |
| 08/29/2000 | US6110740 Human vault RNA |
| 08/29/2000 | US6110738 Amino acid and nucleotide sequences of forkhead activin signal tranducer gene; protein binds to human smad2 and activates an activin response element; for screening test compounds which modulate transforming growth factor-beta |
| 08/29/2000 | US6110737 Nucleotide sequence; enhancing response of cells; determining regions involved in signal transduction; drug screening; for mutants; anticarcinogenic agents; wound healing agents; antiproliferative agents; prevention of atherosclerosis |
| 08/29/2000 | US6110736 Excising region of dna introduced in the genome of a plant cell and flanked by pair of directly repeated site-specific recombination seuqences by generating flp recombinase activity in cell, and identifying cells with excised regions |